Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of progression-free (PFS) and overall survival (OS) at 3-5 years ...

Lymphocyte-predominant Hodgkin's lymphoma (LPHL) is a rare disease, which differs substantially from classical Hodgkin's lymphoma (cHL) with regard to histopathology and clinical course.

Takeda and Seattle Genetics are closing in on a new front-line use for their Adcetris in classical Hodgkin lymphoma after a successful late-stage trial. The positive results from the phase 3 ...

Study shows that using immune checkpoint inhibitors before allogeneic transplantation improves overall survival and ...